Pluristem Therapeutics

- NASDAQ:PSTI
Last Updated 2021-07-20
  • Therapeutic Products Derived from Non-Controversial Adult Stem Cell Source
  • Locations

    • Haifa Hefa
  • Total Funding (USD)

    15.0 million
  • Industries

    Mobile Apps
  • Security

    Type: ORD
    CUSIP: 72940R102
    ISIN: US72940R1023
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.